Ulrich Burger

Title: Ulrich Burger: Innovator in Pharmaceutical Composition

Introduction

Ulrich Burger is a notable inventor based in Geneva, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the modulation of immune reactions. His innovative work has led to the development of a unique pharmaceutical composition that has the potential to impact the treatment of various conditions.

Latest Patents

Ulrich Burger holds 1 patent for his invention titled "Pharmaceutical composition and method for modulating the immune reaction." This patent describes pharmaceutical compositions for the modulation of the immune reaction of warm-blooded animals. The compositions are derivatives of 2-oxindole-3-acetic acid or 2-oxo-1,2,3,4-tetrahydroquinoline-4-carboxylic acid. The derivatives can exist in equilibrium with each other and include both previously described compounds and new compounds. Notably, the patent also details new derivatives of these acids, including the pure antipodes of the mixture of enantiomers of the 2-oxo-1,2,3,4-tetrahydroquinoline-4-carboxylic acid.

Career Highlights

Ulrich Burger is associated with Cerbios-Pharma SA, a company that focuses on the development and manufacturing of pharmaceutical products. His work at Cerbios-Pharma has allowed him to explore innovative solutions in the pharmaceutical industry, contributing to advancements in drug development.

Collaborations

Throughout his career, Ulrich has collaborated with notable professionals in the field, including Jean-Claude Jaton and Fabrizio Marazza. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Ulrich Burger's contributions to pharmaceutical compositions demonstrate his commitment to advancing medical science. His innovative patent reflects a significant step forward in the modulation of immune reactions, showcasing the potential for new therapeutic approaches.